To determine the ability of dual-arterial phase gadoxetic acid–enhanced CAIPIRINHA MRI in preoperative assessment of hepatic vasculature in potential living liver donors with CTA as the reference standard.
To determine the ability of dual-arterial phase gadoxetic acid–enhanced CAIPIRINHA MRI in preoperative assessment of hepatic vasculature in potential living liver donors with CTA as the reference standard.